EyePoint Pharmaceuticals, Inc. Earnings Per Share, Basic in USD/shares from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2010 to Q3 2025.
  • EyePoint Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.85 USD/shares, a 57.4% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -3 USD/shares, a 50.8% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was -2.32 USD/shares, a 27.5% decline from 2023.
  • EyePoint Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -1.82 USD/shares, a 33.6% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -2.74 USD/shares, a 35% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

EyePoint Pharmaceuticals, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$3 -$1 $0 -57.4% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$2 -$1 $0 -46.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$2 -$1 $0 -18.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$2 -$1 $0 -103% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-06
Q3 2024 -$1 -$1 $0 -63.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$1 -$1 +$0.03 +4.92% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$1 -$1 +$0.01 +1.79% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 -$1 $0 +$0.85 +72.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-06
Q3 2023 -$2 $0 +$0.16 +32.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$2 -$1 $0 -17.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$2 -$1 $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$2 -$1 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $0 +$0.09 +15.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$1 $0 -48.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q2 2016 $0 $0 $0 -5.88% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-13
Q1 2016 $0 $0 +$0.02 +11.8% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $0 $0 $0 -28.6% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $0 $0 -$1 -124% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $0 $0 $0 -21.4% Apr 1, 2015 Jun 30, 2015 10-K 2016-09-13
Q1 2015 $0 $0 $0 -113% Jan 1, 2015 Mar 31, 2015 10-K 2016-09-13
Q4 2014 $0 $0 $0 -7.69% Oct 1, 2014 Dec 31, 2014 10-K 2016-09-13
Q3 2014 $0 $0.70 +$0.84 Jul 1, 2014 Sep 30, 2014 10-K 2016-09-13
Q2 2014 $0 $0 Apr 1, 2014 Jun 30, 2014 10-K 2016-09-13
Q1 2014 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $0 Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07

EyePoint Pharmaceuticals, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2 -$1 -27.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 -$2 +$0.92 +33.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 -$3 -$1 -35% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 -$2 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2017 -$1 +$0.16 +23.5% Jul 1, 2016 Jun 30, 2017 10-K 2017-09-13
2016 -$1 -$1 -409% Jul 1, 2015 Jun 30, 2016 10-K 2017-09-13
2015 $0.22 +$0.71 Jul 1, 2014 Jun 30, 2015 10-K 2017-09-13
2014 $0 +$0.03 +5.77% Jul 1, 2013 Jun 30, 2014 10-K 2016-09-13
2013 -$1 +$0.67 +56.3% Jul 1, 2012 Jun 30, 2013 10-K 2015-09-10
2012 -$1 -$1 -170% Jul 1, 2011 Jun 30, 2012 10-K 2012-09-27
2011 $0 -$1 -192% Jul 1, 2010 Jun 30, 2011 10-K 2012-09-27
2010 $0.48 Jul 1, 2009 Jun 30, 2010 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.